| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.16 | 0.0007 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |